Skip to content
Screener

Vanda Pharmaceuticals VNDA Q1 2026 earnings

Reported May 6, 2026 · After market close

Revenue$51.7MMiss by $3.3M
EPS-$0.82Miss by $0.29
Revenue estimate$55.0M
EPS estimate-$0.53

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$69.3M
EPS estimate-$0.72

FAQ

When did Vanda Pharmaceuticals report Q1 2026 earnings?
Vanda Pharmaceuticals (VNDA) reported Q1 2026 earnings on May 6, 2026 after market close.
What were Vanda Pharmaceuticals's Q1 2026 revenue and EPS?
Vanda Pharmaceuticals reported revenue of $51.7M and eps of $-0.82 for Q1 2026.
Did Vanda Pharmaceuticals beat estimates in Q1 2026?
Revenue missed the consensus estimate of $55.0M by $3.3M. EPS missed the consensus estimate of $-0.53 by $0.29.
How did Vanda Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.4% from $50.0M a year earlier and eps declined 64.0% from $-0.50.
Where can I find Vanda Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-031241) and the 10-Q periodic report (0001628280-26-031667) directly on SEC EDGAR. The filing index links above go to sec.gov.